Sunday - November 17, 2019
AbbVie Assigned Patent for Synthetic Route to Anti-Viral Agents
Copyright © Targeted News Service, 2019
2019-10-19
ALEXANDRIA, Va., Oct. 19 -- AbbVie, North Chicago, Illinois, has been assigned a patent (No. 10,442,792, initially filed Sept. 17, 2018) developed by 15 co-inventors for a "synthetic route to anti-viral agents." The co-inventors are Russell D. Cink, Grayslake, Illinois, Kirill A. Lukin, Vernon Hills, Illinois, Marvin R. Leanna, Grayslake, Illinois, Matthew J. Pelc, Pleasant Prairie, Wisconsin, Timothy B. Towne, Lindenhurst, Illinois, Dennie S. Welch, Gurnee, Illinois, Kenneth M. Engstrom, Mundel . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information or a free trial

Copyright Targeted News Service 2019